These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1309376

  • 41. The cyclooxygenase theory of aspirin-induced asthma.
    Szczeklik A.
    Eur Respir J; 1990 May; 3(5):588-93. PubMed ID: 2115849
    [Abstract] [Full Text] [Related]

  • 42. Leukotrienes in the blood and urine of children with acute asthma.
    Sampson AP, Green CP, Spencer DA, Piper PJ, Price JF.
    Ann N Y Acad Sci; 1991 May; 629():437-9. PubMed ID: 1659289
    [No Abstract] [Full Text] [Related]

  • 43. Mechanism of bronchospasm in aspirin-sensitive asthma.
    Lee TH.
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1442-3. PubMed ID: 8256882
    [No Abstract] [Full Text] [Related]

  • 44. The protective effects of leukotriene modifiers in aspirin-induced asthma.
    Israel E.
    Postgrad Med; 2000 Sep 15; 108(4 Suppl):40-4. PubMed ID: 19667532
    [Abstract] [Full Text] [Related]

  • 45. Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome.
    Fauler J, Tsikas D, Holch M, Seekamp A, Nerlich ML, Sturm J, Frölich JC.
    Clin Sci (Lond); 1991 May 15; 80(5):497-504. PubMed ID: 1851691
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Asthma induced by aspirin and arachidonic acid metabolites. Role of leukotrienes (third part)].
    Salazar Villa RM, Zambrano Villa S.
    Rev Alerg Mex; 1994 May 15; 41(2):51-7. PubMed ID: 7804810
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Leukotrienes and aspirin induced asthma.
    Lee TH, Christie PE.
    Thorax; 1993 Dec 15; 48(12):1189-90. PubMed ID: 8303620
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency.
    Mayatepek E, Hoffmann GF, Bremer HJ.
    J Pediatr; 1993 Jul 15; 123(1):96-8. PubMed ID: 8391572
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Urinary leukotriene E4 is a biomarker for chronic rhinosinusitis associated with leukotriene dysregulation irrespective of aspirin sensitivity status.
    Idler BM, Lal D, Marino MJ.
    Int Forum Allergy Rhinol; 2022 May 15; 12(5):805-808. PubMed ID: 34821062
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Bioactive mediators in asthma.
    Smith LJ.
    Chest; 1992 Jun 15; 101(6 Suppl):381S-384S. PubMed ID: 1317278
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.